Celebrating our 10th anniversary – Unlock our special offer today

Marketing and Retailing

FDA told it should abandon deeming regs, turn to Congress

10th August 2014 - News analysis |

The U.S. Food and Drug Administration (FDA) is likely to have received a deluge of comments in the run-up to the closing of the public consultation period on its e-cigarette regulations last Friday – among them a biting critique of the agency’s approach from a U.S. vapers’ group.

Blu still on top, but faltering; Lorillard remains optimistic

31st July 2014 - News analysis |

Lorillard’s brand Blu retains around a 40% share of the U.S. mainstream retail market for e-cigarettes, an enviable position in many categories. But there are signs in the firm’s latest financial results and in measurement data that its ascendance is slowing, and that if Imperial Tobacco takes over the Blu brand as expected early next year, it will not be inheriting an unstoppable market leader.

To stock or not to stock? Pharmacists uncertain on e-cigs

16th May 2014 - News analysis |

British pharmacies have yet to fully exploit the retail opportunities presented by e-cigarettes, according to a prominent market researcher, although pharmacy professionals themselves disagree vehemently over how to approach e-cigs that aren’t medically licensed.

FDA’s product approval process is biggest worry for e-cig sector

25th April 2014 - News analysis |

The deeming regulations on e-cigarettes issued yesterday by the U.S. Food and Drug Administration (FDA) were largely expected by the industry and greeted without panic, although concerns were raised over the product approval process and the underlying philosophy of regulating all nicotine-containing products in a similar way.

New FDA rules and Europe’s directive: how do they compare?

25th April 2014 - News analysis |

The new regulations for e-cigarettes proposed yesterday by the U.S. Food and Drug Administration (FDA) are the second major regulatory framework for the products to appear in two months, following the European Union’s release of its revised Tobacco Products Directive (TPD) earlier this year. How do the two compare in key areas?